Ardent Health Earnings Call Highlights Margin Momentum

Ardent Health Partners, Inc. ((ARDT)) has held its Q1 earnings call. Read on for the main highlights of the call.

Ardent Health Partners opened its latest earnings call on an upbeat note, emphasizing strong revenue growth, expanding margins, and tight cost control despite pockets of pressure from payer mix, professional fees, and malpractice costs. Management framed the quarter as evidence that its IMPACT cost program and growth initiatives are outweighing weather‑related volume softness and exchange reimbursement headwinds.

Revenue Growth

Ardent reported first‑quarter revenue of $1.6 billion, a 7% increase from a year earlier that underscores steady demand across its markets. Management highlighted this top‑line growth despite fewer overall admissions, pointing to higher acuity and continued shift toward outpatient services as key drivers of revenue resilience.

Strong EBITDA and Margin Expansion

Adjusted EBITDA surged 26% year over year to $124 million, lifting the adjusted EBITDA margin by 110 basis points to 7.7%. Even excluding a $10.9 million investment gain, EBITDA still grew 15%, while pre‑NCI adjusted EBITDAR margin improved to 11.5%, reflecting broad‑based operational leverage and cost discipline.

Volume and Service Line Performance

Adjusted admissions rose 2%, squarely within the midpoint of Ardent’s 2026 guidance range of 1.5% to 2.5%, even as total admissions fell 1.1%. Total surgeries increased 1.2% with outpatient procedures up 1.7%, reinforcing the company’s strategic tilt toward higher‑margin ambulatory and same‑day surgery volumes.

IMPACT Program Savings and Execution

Management stressed that the IMPACT program is on track to deliver $55 million of savings in 2026, with benefits already flowing through the P&L since late 2025. These initiatives, spanning staffing optimization, procurement, and process redesign, were credited as key contributors to margin expansion and the higher quality of earnings.

Labor and Contract Labor Improvements

Salaries, wages, and benefits expense per adjusted admission fell 1.4% in the quarter, a rare achievement in today’s tight labor market. Contract labor expense dropped more than 40% to $15 million, reducing contract labor to 2.2% of SW&B from 3.8% last year and easing a major industry‑wide cost pressure.

Supply Chain and Cost Controls

Supply expense per adjusted admission increased a modest 1.7%, but supply costs as a percentage of revenue improved by 50 basis points. Ardent attributed this to vendor consolidation, renegotiated distribution contracts, and better rebate structures, which collectively helped protect margins from inflationary and utilization pressures.

Balance Sheet and Liquidity Strength

The company ended the quarter with $610 million of cash, $1.1 billion of total debt, and $0.9 billion of available liquidity, supporting a total net leverage ratio of just 1.0x. Lease‑adjusted net leverage improved to 2.6x from 3.0x a year earlier, giving Ardent ample balance‑sheet flexibility to invest in growth while weathering external volatility.

Ambulatory and Access Expansion

Ardent opened four urgent care centers across Texas, New Mexico, and Idaho during the quarter, enhancing same‑day access and feeder channels to its hospitals and surgery centers. For the remainder of 2026, plans include two ambulatory surgery centers, one freestanding emergency department, and one more urgent care site to fuel incremental, higher‑margin volumes.

Technology and Care Transformation Initiatives

The company announced an enterprise‑wide virtual care partnership with hellocare.ai that will extend AI‑assisted services to more than 2,000 patient rooms. Virtual patient monitoring is already live and is expected to bolster patient safety and labor efficiency as the rollout completes by year‑end, potentially unlocking further productivity gains.

Operational Metrics and Seasonality Management

Ardent pointed to more precise staffing practices that limited SW&B growth to just 0.6% in the quarter, even while implementing IMPACT initiatives. The team also managed through severe winter storms and an unusually light flu season by rescheduling surgeries and flexing labor, helping smooth what might otherwise have been sharper seasonal swings.

Transient Volume Softness and Weather Impact

Despite growth in adjusted admissions, headline admissions declined 1.1% as storms in Texas, Oklahoma, and New Jersey disrupted normal patterns. A muted respiratory and flu season further reduced typical Q1 hospital traffic, which management characterized as transient rather than structural, with some volumes shifted rather than permanently lost.

Exchange/Payer Mix Headwind

Management estimated roughly a $35 million EBITDA headwind tied to exchange dynamics, driven more by mix than by volume. While exchange admissions rose about 1% to 2%, a 12% shift from silver to lower‑premium bronze plans boosted patient cost sharing, pressured revenue yield, and created heightened exposure to disenrollments and clawbacks.

Professional Fees Pressure

Professional fees climbed 100 basis points as a share of revenue year over year and rose 2.4% sequentially in the quarter. Leadership noted that compensation dynamics will keep year‑over‑year comparisons elevated through mid‑year, but they expect this line item to moderate to high‑single‑digit growth in the back half of 2026.

Medical Malpractice Premium Increase

A step‑up in medical malpractice premiums, particularly in New Mexico, added an estimated $10 million to $11 million of expense versus last year. While recent legislative caps are expected to provide relief over time, management cautioned that malpractice costs will remain a near‑term headwind to earnings performance.

Cash Used in Operating Activities

The company used $60 million of cash in operating activities in Q1 2026 compared with $25 million a year earlier, though the prior period benefited from insurance proceeds related to a 2023 cybersecurity incident. Executives reminded investors that the first quarter is typically the weakest for cash flow because of payment timing tied to year‑end accruals.

Denials and Revenue Recovery Risk

Payer denials remain elevated across the industry, and Ardent acknowledged that they continue to pose a risk to revenue integrity and cash conversion. Although denial levels were stable versus late 2025 and the company is working with Ensemble to strengthen denial management and recoveries, this area remains a key watchpoint.

Guidance and Outlook

Management reaffirmed full‑year revenue and adjusted EBITDA guidance as well as its adjusted admissions growth outlook of 1.5% to 2.5% for 2026, resisting the urge to raise targets after a strong start. They underscored confidence in achieving $55 million of IMPACT savings, while flagging exchange dynamics, macro uncertainties, and professional fee trends as reasons for maintaining a cautious stance.

Ardent’s earnings call painted a picture of a health system gaining operational traction, with expanding margins, disciplined cost control, and a stronger balance sheet offsetting payer mix and legal cost pressures. For investors tracking hospital operators, the quarter suggests a company executing well on self‑help initiatives while keeping expectations grounded in a still‑choppy reimbursement and volume environment.